The need
Accurate + Predictive + Non-Invasive
Mission critical cardiac monitoring for critical care, operating rooms and heart failure patients has historically required invasive pulmonary catheters and implants. We aim to change that.
The platform
Next Generation Capabilities
Our approach combines a unique physiological signal, off-the-shelf sensors, and cloud computing to predict patient health.
The results
Game Changing Potential
Our early clinical studies show that Respirix can already predict 87% of the signal in an implant that is the standard of care for heart failure monitoring.
Team
Eric Kriegstein
MBA
Daniel Burnett
MD, MBA
Michael Jaasma
PhD
Evan Luxon
MS, MSE
Alex Vergara
MS
Carin Lindquist
Advisors
Riccardo Turchetto
Geoffrey Tison
MD, MPH
Tessa Walters
MD
Paul L. Marino
MD, PhD
Support From
